DEUTSCHE BANK AG\

Holdings History for Amylyx Pharmaceuticals, Inc. - Common Stock, $0.0001 par value per share (AMLX)

Symbol: AMLX on Nasdaq
Investment type: Equity / Common Stock, $0.0001 par value per share

Shares, Excluding Options vs Price

Value, Excluding Options

Holdings date	Weight	Change	Value $	Shares	Change	Activity %	Price	All Holders
31 Dec 2025	0.01%	-0%	$16,105,491	1,333,236	-32,285	-2.4%	$12.08	Q4 2025
30 Sep 2025	0.01%	+0%	$18,557,430	1,365,521	+748,602	+121%	$13.59	Q3 2025
30 Jun 2025	0%	+0%	$3,954,451	616,919	+46,062	+8.1%	$6.41	Q2 2025
31 Mar 2025	0%	0%	$2,020,834	570,857	0		$3.54	Q1 2025
31 Dec 2024	0%	0%	$2,157,839	570,857	0		$3.78	Q4 2024
30 Sep 2024	0%	0%	$1,849,577	570,857	0		$3.24	Q3 2024
30 Jun 2024	0%	-0%	$1,084,628	570,857	-185,312		$1.90	Q2 2024
31 Mar 2024	0%	-0%	$2,147,520	756,169	-96,831		$2.84	Q1 2024
31 Dec 2023	0.01%	+0.01%	$12,556,160	853,000	+828,584	+3394%	$14.72	Q4 2023
30 Sep 2023	0%	-0%	$447,057	24,416	-167,195	-87%	$18.31	Q3 2023
30 Jun 2023	0%	+0%	$4,133,049	191,611	+160,291	+512%	$21.57	Q2 2023
31 Mar 2023	0%	+0%	$918,929	31,320	+9,359	+43%	$29.34	Q1 2023
31 Dec 2022	0%	+0%	$811,459	21,961	+6,977	+47%	$36.95	Q4 2022
30 Sep 2022	0%	+0%	$422,000	14,984	+10,292	+219%	$28.16	Q3 2022
30 Jun 2022	0%	-0%	$90,000	4,692	-657	-12%	$19.18	Q2 2022
31 Mar 2022	0%	+0%	$69,000	5,349	+5,349	NEW	$12.90	Q1 2022

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.